Institutional-grade intelligence for every Medicare-certified hospice provider in the United States — quality reporting, ownership structure, compliance patterns, and care delivery data. Built on the same federal data infrastructure as our SNF and home health verticals.
No commitment. First access when the vertical launches.
The same federal data infrastructure that powers our SNF and home health verticals exists for hospice. CMS publishes quality reporting, CAHPS patient experience surveys, claims-based outcomes, and ownership data for all Medicare-certified hospice providers. We're building the institutional intelligence layer on top of it.
Name, address, ownership type, certification date, Medicare participation, care settings offered, geographic service area.
Hospice Outcomes and Patient Evaluation tool — composite process measure, seven component quality measures, claims-based outcome indicators.
Eight patient experience measures including care of patients, communication, emotional and spiritual support, and willingness to recommend.
Ten claims-based indicators including continuous home care utilization, burdensome transitions, live discharge patterns, and late hospice enrollment rates.
Direct and indirect ownership structure, change of ownership transaction history since 2016, chain affiliation, for-profit vs. non-profit classification.
CareIndex composite score weighting quality measures, patient experience, care index indicators, and compliance posture into a single actionable grade.
The hospice market is under more regulatory and financial scrutiny than at any point in the past decade. Four developments are converging simultaneously.
In its FY2027 proposed rule, CMS unveiled a new publicly available hospice scoring system based on indicators of potential inappropriate utilization, quality of care, and compliance concerns — a Service and Spending Variation Index assigned to every provider. This is the same transparency push that preceded heightened SNF scrutiny. Institutional buyers need independent intelligence before CMS publishes it.
CMS found that in CY2025, roughly 20% of hospices failed to meet Hospice Quality Reporting Program requirements — consistent with prior years. For investors and operators, this means quality data is missing for 1 in 5 providers on Care Compare. Knowing which providers have suppressed data vs. genuinely poor performance requires a data layer Care Compare doesn't provide.
Between 2021 and 2022 alone, the number of hospice agencies grew 16% — almost entirely driven by for-profit growth. For-profit hospices now represent approximately three-quarters of the market. CMS has revoked or deactivated hundreds of hospice providers for improper activity in elevated-fraud states including Arizona, California, Nevada, Texas, Georgia, and Ohio. Ownership intelligence is essential for acquisition due diligence.
For the first time, 53.1% of all Medicare decedents in 2024 received hospice care at the time of death — the third consecutive year of increases. As utilization grows, so does the market's attractiveness to PE, REITs, and regional operators. The same investor intelligence workflow used for SNF and home health acquisitions applies directly to hospice.
CareIndex is the only research institution building institutional intelligence across all three post-acute care settings from the same federal data infrastructure.
Any serious institutional buyer — PE firm evaluating a post-acute platform, REIT with diversified holdings, multi-line operator — has exposure to all three care settings. CareIndex is building the only platform that scores and benchmarks the full continuum from a single data infrastructure. Join the waitlist to get first access when hospice launches.
We'll notify you as soon as hospice intelligence is available — including early access to the provider database and report products before public launch.
